Can existing #ProteaseInhibitors block #SARS-CoV-2 entry?
This study shows lopinavir/ritonavir binds to the spike RBD, a key viral entry site, supporting rational drug design. #medsky #Virology
#BIOI #OpenAccess: doi.org/10.15212/bio...